EssilorLuxottica (ESLOY) Stock Forecast and Price Target (2026)

Last updated November 2026

Short answer

There is no meaningful price-target consensus for EssilorLuxottica (ESLOY): too few analysts publish a target on it for an average to mean anything. Thin coverage is normal for smaller and newer companies and says nothing about the business. What does exist is an earnings forecast. For the fiscal year ending Dec 2026, the 20 analysts publishing estimates on ESLOY expect earnings of $4.11 per share (+2.0% on the year before) and revenue of 30.1 billion EUR (+5.8%). The full quarter and fiscal-year estimates are below, with the drivers and risks that decide whether they are met. Walnut is not an investment adviser.

Why ESLOY has no consensus price target

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. ESLOY is one of them. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model.

Trailing reported earnings understate the business because they include amortisation from the 2018 merger and other acquisitions; adjusted net profit was ~€3.16 billion in 2025 and ~€1.92 billion in the first half of 2026. On forward estimates the ADR trades near ~22x, down from well above 40x at the late 2025 peak and roughly in line with large European consumer health names. EV/EBITDA is ~18x on Yahoo's figures, and the price is ~3x sales. The two analysts Yahoo tracks on the ADR have a mean target of ~$132.50, well above the ~$96 close. Net debt of ~€13.4 billion is about 2x EBITDA. Each ESLOY ADR equals 0.5 ordinary shares, so the ADR price is roughly half the Paris price converted into dollars at ~$1.11 per euro.

ESLOY earnings and revenue forecast

For the fiscal year ending Dec 2026, the 20 analysts publishing estimates on ESLOY expect earnings of $4.11 per share (+2.0% on the year before) and revenue of 30.1 billion EUR (+5.8%).

PeriodEPS estimateEPS growthRevenue estimateRevenue growth
Quarter ending Dec 2026
next quarter to report, 1 analyst
--7.8 billion EUR+2.4%
Fiscal year ending Dec 2026
fiscal year next to report, 20 analysts
$4.11+2.0%30.1 billion EUR
29.9 billion EUR to 30.6 billion EUR
+5.8%
Fiscal year ending Dec 2027
the fiscal year after, 20 analysts
$4.44+7.9%32.6 billion EUR
32 billion EUR to 34.2 billion EUR
+8.1%

Consensus estimates for ESLOY published by sell-side analysts, as of November 2026, from Yahoo Finance. Each figure is the average of the analysts counted, with the lowest and highest estimate beneath it; growth compares with the same period a year earlier and is left blank where either figure is a loss. Estimates change constantly. Walnut is not an investment adviser.

Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level.

Is there a 2030 forecast for ESLOY?

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering ESLOY do not put out a 2030 number. Anything presenting one is extrapolating a growth rate of its own, and a figure produced that way tells you about the assumption chosen, not about the company.

The furthest-out consensus that exists is for the fiscal year ending Dec 2027: analysts expect earnings of $4.44 per share, +7.9% on the fiscal year ending Dec 2026 estimate of $4.11. Beyond that, nobody publishes estimates, so any later number is an extrapolation.

On the figures we hold as of November 2026, ESLOY trades at about 30.7 times trailing earnings and 21.6 times forward earnings. A forward multiple below the trailing one means the market expects earnings to grow, and the size of that gap is roughly how much growth is already in the price.

For a ten-year question, that frame is more useful. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether EssilorLuxottica can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

What could move ESLOY from here

In short: the drivers cited most often are AI glasses and the Meta partnership, Myopia management and medtech, Retail and direct-to-consumer growth. The risk cited most often against it is wearables are the largest swing factor.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the ESLOY is it a buy page.

Your questions about EssilorLuxottica

Ask Walnut's AI anything about ESLOY and see how it fits what you own.

FAQ

What is the price target for EssilorLuxottica (ESLOY)?

+

There is no meaningful consensus price target for ESLOY, because too few analysts publish on it. Thin coverage is common for smaller and newer companies. Where only one or two analysts cover a stock, an "average target" is really one person's model, so we do not print a number that would imply more agreement than exists. Check your broker's research tab for whatever individual coverage exists.

Is there an analyst forecast for ESLOY?

+

For earnings, yes; for the share price, not a meaningful one. For the fiscal year ending Dec 2026, the 20 analysts publishing estimates on ESLOY expect earnings of $4.11 per share (+2.0% on the year before) and revenue of 30.1 billion EUR (+5.8%). Fewer analysts publish a price target on ESLOY than publish earnings estimates, which is common for smaller and newer companies, and a lack of target coverage says nothing about the business itself.

What are analysts' earnings estimates for EssilorLuxottica (ESLOY)?

+

For the fiscal year ending Dec 2026, the 20 analysts publishing estimates on ESLOY expect earnings of $4.11 per share (+2.0% on the year before) and revenue of 30.1 billion EUR (+5.8%). For the fiscal year ending Dec 2027, the consensus is $4.44 per share, +7.9% on the year before. These are consensus estimates as of November 2026, the average of what the covering analysts publish, and they are revised constantly, especially around each earnings report. They describe expectations, not results.

What could move ESLOY?

+

The drivers and the risks are laid out on this page and in more depth on the ESLOY "is it a buy" page. Without analyst estimates to anchor to, the useful framing is a set of scenarios.

Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a November 2026 data pull of published third-party research, are approximate, and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026, and every percentage against it on this page is measured from that price. Verify current figures with your broker before acting on them.

Forecasts for similar stocks